ICD-10-CM D22 is the diagnosis code for Melanocytic nevi. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where D22 sits in the ICD-10-CM classification helps ensure proper coding:
No, D22 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D22 is the ICD-10-CM diagnosis code for "Melanocytic nevi". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D22 is located in Section D10-D36 — "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D22 has 9 sub-code(s) that provide more specific detail: D22.0, D22.1, D22.2, D22.3, D22.4 and more.
Use D22 when the patients documented diagnosis matches "Melanocytic nevi" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Melanocytic nevi is D22.
No, D22 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D22 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D22 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.